Menu

News Releases

SEARCH:

VB-2

Abattis Bioceuticals is a life sciences company that aggregates, integrates, and invests in biotechnology services internationally.

Exchange Listings
CSE: ATT | OTC: ATTBF

Subscribe To Our News List
Sign up to receive alerts on Abattis news releases and product announcements

Email:

Abattis Bioceuticals Corporation

T: 1-604-681-1269

Follow @abattis

Copyright ©2019 Abattis Bioceuticals. All Rights Reserved

Disclaimer
Privacy Policy
Terms and Conditions
Return Policy